Melissa S. Dillmon

Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology–Cancer Care Ontario Focused Guideline Update

Catherine Van Poznak, Mark R. Somerfield, William E. Barlow et al. · Journal of Clinical Oncology · 2017 · 180 citations

Medicine, Oncology, Pharmacotherapy +17

American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer Care

Nathan A. Pennell, Melissa S. Dillmon, Laura A. Levit et al. · Journal of Clinical Oncology · 2020 · 85 citations · Full text

Medicine, Clinical Sciences, Oncology +17

Differential Outcomes in Codon 12/13 and Codon 61 <i>NRAS</i> -Mutated Cancers in the Phase II NCI-MATCH Trial of Binimetinib in Patients with <i>NRAS</i> -Mutated Tumors

James M. Cleary, Victoria Wang, Rebecca S. Heist et al. · Clinical Cancer Research · 2021 · 38 citations · Full text

Pharmacy, Pharmacology, Oncology Pharmacotherapy +12

Unusual Thromboses Associated with Protein S Deficiency in Patients with Acquired Immunodeficiency Syndrome: Case Reports and Review of the Literature

Melissa S. Dillmon, Michael S. Saag, Sate Hamza et al. · AIDS Research and Human Retroviruses · 2005 · 28 citations

Medicine, Hematology, Infectious Diseases +17

Comparison of Radiation With or Without Concurrent Trastuzumab for HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy: A Phase III Clinical Trial

Melody Cobleigh, Stewart Anderson, Kalliopi P. Siziopikou et al. · Journal of Clinical Oncology · 2021 · 28 citations · Full text

Medicine, Oncology, Radiation Oncology +17